Our Pricing

Ozempic vs Mounjaro: Clinical Comparison for Weight Loss

Published on: June 03, 2026

When comparing ozempic vs mounjaro uk options, understanding the clinical differences between semaglutide and tirzepatide is essential for informed decision-making. Both medications are currently in stock at Cured Pharmacy, with transparent pricing and same-day prescriber assessments available for eligible patients. Our UK-registered clinical team, led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073), provides comprehensive consultations to determine which treatment aligns with your weight loss goals.

Ozempic vs Mounjaro UK: Mechanism of Action

Ozempic contains semaglutide, a GLP-1 receptor agonist that mimics the natural hormone glucagon-like peptide-1 to regulate appetite and blood glucose levels [1]. Originally licensed for type 2 diabetes management, semaglutide has demonstrated significant weight loss effects in clinical populations, leading to its widespread use in weight management programmes.

Mounjaro represents a newer generation of treatment, containing tirzepatide—the first dual GIP/GLP-1 receptor agonist licensed by the MHRA [2]. By activating both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors simultaneously, tirzepatide produces enhanced metabolic effects compared to single-pathway medications. This dual mechanism may explain the superior weight reduction observed in head-to-head clinical trials [3].

The pharmacological distinction between these medications influences both efficacy and tolerability profiles. Patients switching between treatments should expect a supervised transition period, as receptor activation patterns differ substantially between semaglutide and tirzepatide formulations.

Clinical Trial Data: Weight Loss Outcomes

The STEP programme evaluated semaglutide 2.4mg weekly injections in adults with obesity, demonstrating an average weight reduction of 14.9% over 68 weeks compared to 2.4% with placebo [1]. Participants maintained clinically meaningful weight loss throughout the trial period, with approximately 50% achieving at least 15% body weight reduction.

Tirzepatide's SURPASS-2 trial directly compared the highest dose (15mg) against semaglutide 1mg in patients with type 2 diabetes, showing superior glycaemic control and weight reduction with tirzepatide [3]. The SURMOUNT-1 trial specifically examined tirzepatide for weight management in non-diabetic adults, reporting average reductions of 15.0%, 19.5%, and 20.9% with 5mg, 10mg, and 15mg doses respectively over 72 weeks [2].

Both medications require gradual dose escalation to minimise gastrointestinal side effects. Your UK prescriber will determine the appropriate starting dose and titration schedule based on your medical history, current medications, and weight loss objectives.

Real-World Effectiveness Considerations

Clinical trial populations differ from real-world patients in important ways. Trial participants typically receive intensive dietary counselling, regular monitoring, and psychological support that may not reflect routine clinical practice. At Cured Pharmacy, our prescribers emphasise that medication forms one component of comprehensive weight management, alongside nutritional modification and physical activity.

Ozempic vs Mounjaro: Side Effect Profiles

Both semaglutide and tirzepatide share common gastrointestinal side effects due to their effects on gastric emptying and satiety signalling. Nausea occurs in approximately 44% of patients initiating semaglutide and 34-43% with tirzepatide, typically diminishing after the initial titration phase [1][2]. Diarrhoea, constipation, and abdominal discomfort represent other frequently reported effects.

Serious adverse events remain rare but require clinical awareness. Pancreatitis has been reported with GLP-1 receptor agonists, though causality remains uncertain [4]. Patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should not use either medication due to theoretical thyroid C-cell tumour risk observed in rodent studies [4].

Hypoglycaemia risk increases when these medications are combined with insulin or sulfonylureas. Your prescriber will review all current medications during consultation to identify potential interactions and adjust doses accordingly. All prescription treatments dispensed by Cured Pharmacy include comprehensive patient information leaflets detailing side effects and warning signs requiring medical attention.

Managing Common Side Effects

Most gastrointestinal symptoms can be minimised through slower dose titration, smaller meal portions, and avoiding high-fat foods. Patients should contact their prescriber if nausea persists beyond the first month or if severe abdominal pain develops, as dose adjustment may be necessary.

Dosing Schedules and Administration

Ozempic is administered as a once-weekly subcutaneous injection, with standard weight loss protocols starting at 0.25mg weekly for four weeks, then escalating to 0.5mg, 1mg, and potentially 2mg based on tolerability and response. The pre-filled pen device allows patients to self-administer injections at home following initial training.

Mounjaro follows a similar weekly injection schedule but uses different dose increments: 2.5mg for four weeks, then 5mg, with potential escalation to 7.5mg, 10mg, 12.5mg, or 15mg depending on individual response [2]. The KwikPen device features a hidden needle design that may reduce injection anxiety for needle-averse patients.

Both medications should be injected into the abdomen, thigh, or upper arm, rotating injection sites weekly to prevent lipohypertrophy. Patients can change their injection day if needed, provided at least 72 hours separate consecutive doses. Missed doses should be administered within five days; beyond that timeframe, patients should skip the dose and resume their regular schedule.

Availability and Pricing at Cured Pharmacy

Both Ozempic and Mounjaro are currently in stock at Cured Pharmacy, with Mounjaro available from £124.99 per pen. Unlike many UK pharmacies that require payment before revealing costs, we display transparent upfront pricing before you begin your clinical consultation. This allows you to make informed decisions about treatment affordability without obligation.

All weight loss medications at Cured Pharmacy require completion of a free online clinical assessment, typically taking under three minutes. Our UK-registered prescribers review your medical history, current medications, and weight loss goals to determine suitability. If approved, your prescription is dispensed by our GPhC-registered pharmacy (9012511) and dispatched in discreet packaging with tracked delivery.

We guarantee the lowest prices in the UK for genuine, MHRA-licensed medications. Every product dispensed carries full manufacturer packaging and patient information leaflets. Our clinical team remains available throughout your treatment journey to address questions, monitor progress, and adjust prescriptions as needed.

What to Expect During Your Consultation

Your online assessment covers medical history, current medications, previous weight loss attempts, and contraindications. Our prescribers may request additional information or recommend alternative treatments if Ozempic or Mounjaro is not clinically appropriate. All consultations remain confidential and comply with GMC and GPhC professional standards.

Choosing Between Ozempic and Mounjaro

The decision between semaglutide and tirzepatide depends on multiple factors including treatment history, weight loss targets, side effect tolerance, and budget considerations. Patients who have previously used Ozempic or Wegovy may benefit from switching to Mounjaro if weight loss has plateaued, though this requires prescriber approval and careful transition planning.

Clinical trial data suggests tirzepatide may produce greater average weight reduction, but individual responses vary considerably [3]. Some patients achieve excellent results with semaglutide and may not require escalation to dual-agonist therapy. Your prescriber will consider your specific circumstances, including any contraindications or medication interactions.

Both treatments require long-term commitment for sustained results. Weight regain commonly occurs following discontinuation, highlighting the importance of lifestyle modifications alongside pharmacotherapy [5]. At Cured Pharmacy, we provide ongoing prescriber support to optimise treatment duration and develop sustainable weight maintenance strategies.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
3. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
4. Medicines and Healthcare products Regulatory Agency. (2023). GLP-1 receptor agonists: Reports of diabetic ketoacidosis when concomitant insulin was rapidly reduced or discontinued. Drug Safety Update, 16(9). https://www.gov.uk/drug-safety-update [accessed 13 August 2026]
5. Wilding, J. P. H., Batterham, R. L., Davies, M., et al. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism, 24(8), 1553–1564. https://doi.org/10.1111/dom.14725 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on multiple factors including diet, physical activity, and adherence to treatment protocols.